S1P lyase: A novel therapeutic target for ischemia reperfusion injury of the heart

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 300, Issue 5, 2011, Pages

  Bandhuvula, Padmavathi ^a   Honbo, Norman ^b   Wang, Guan Ying ^b   Jin, Zhu Qiu ^b   Fyrst, Henrik ^a   Zhang, Meng ^a   Borowsky, Alexander D ^c   Dillard, Lisa ^c   Karliner, Joel S ^b   Saba, Julie D ^a  

^a CHILDREN S HOSPITAL OAKLAND RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Sgpl1; Sphingolipid; Sphingosine 1 phosphate

Indexed keywords

DRINKING WATER; SPHINGOSINE 1 PHOSPHATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; EX VIVO STUDY; GENE SILENCING; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; REPERFUSION INJURY; SIGNAL TRANSDUCTION; WILD TYPE;

ALDEHYDE-LYASES; ANIMALS; ENZYME INHIBITORS; LYSOPHOSPHOLIPIDS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MODELS, ANIMAL; MUTATION; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; OXIDATIVE STRESS; SPHINGOSINE;

EID: 79955771110     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00946.2010     Document Type: Article

References (37)

1. Bagdanoff J, Donoviel M, Nouraldeen A, Tarver J, Fu Q, Carlsen M, Jessop T, Zhang H, Hazelwood J, Nguyen H, Baugh S, Gardyan M, Terranova K, Barbosa J, Yan J, Bednarz M, Layek S, Courtney L, Taylor J, Digeorge-Foushee A, Gopinathan S, Bruce D, Smith T, Moran L, O'Neill E, Kramer J, Lai Z, Kimball S, Liu Q, Sun W, Yu S, Swaffield J, Wilson A, Main A, Carson K, Oravecz T, Augeri D. Inhibition of sphingosine-1-phosphate lyase for the treatment of autoimmune disorders. J Med Chem 52: 3941-3953, 2009.
2. Bandhuvula P, Fyrst H, Saba J. A rapid fluorescent assay for sphingosine-1-phosphate lyase enzyme activity. J Lipid Res 48: 2769-2778, 2007.
3. Bektas M, Allende ML, Lee BG, Chen W, Amar MJ, Remaley AT, Saba JD, Proia RL. Sphingosine 1-phosphate lyase deficiency disrupts lipid homeostasis in liver. J Biol Chem 285: 10880-10889, 2010.
4. Fyrst H, Saba J. An update on sphingosine-1-phosphate and other sphingolipid mediators. Nat Chem Biol 6: 489-497, 2010.
5. Hait NC, Allegood J, Maceyka M, Strub GM, Harikumar KB, Singh SK, Luo C, Marmorstein R, Kordula T, Milstien S, Spiegel S. Regulation of histone acetylation in the nucleus by sphingosine-1-phosphate. Science 325: 1254-1257, 2009.
6. Hofmann U, Burkard N, Vogt C, Thoma A, Frantz S, Ertl G, Ritter O, Bonz A. Protective effects of sphingosine-1-phosphate receptor agonist treatment after myocardial ischaemia-reperfusion. Cardiovasc Res 83: 285-293, 2009.
7. Igarashi J, Michel T. Sphingosine-1-phosphate and modulation of vascular tone. Cardiovasc Res 82: 212-220, 2009.
8. Jin Z, Karliner J, Vessey D. Ischaemic postconditioning protects isolated mouse hearts against ischaemia/reperfusion injury via sphingosine kinase isoform-1 activation. Cardiovasc Res 79: 134-140, 2008.
9. Jin Z, Zhang J, Huang Y, Hoover H, Vessey D, Karliner J. A sphingosine kinase 1 mutation sensitizes the myocardium to ischemia/ reperfusion injury. Cardiovasc Res 76: 41-50, 2007.
10. Jin Z, Zhou H, Zhu P, Honbo N, Mochly-Rosen D, Messing R, Goetzl E, Karliner J, Gray M. Cardioprotection mediated by sphingosine-1- phosphate and ganglioside GM-1 in wild-type and PKC-e knockout mouse hearts. Am J Physiol Heart Circ Physiol 282: H1970-H1977, 2002.
11. Jin ZQ, Goetzl EJ, Karliner JS. Sphingosine kinase activation mediates ischemic preconditioning in murine heart. Circulation 110: 1980-1989, 2004.
12. Karliner JS, Honbo N, Summers K, Gray MO, Goetzl EJ. The lysophospholipids sphingosine-1-phosphate and lysophosphatidic acid enhance survival during hypoxia in neonatal rat cardiac myocytes. J Mol Cell Cardiol 33: 1713-1717, 2001.
13. Keul P, Sattler K, Levkau B. HDL and its sphingosine-1-phosphate content in cardioprotection. Heart Fail Rev 12: 301-306, 2007.
14. Kumar A, Saba JD. Lyase to live by: sphingosine phosphate lyase as a therapeutic target. Expert Opin Ther Targets 13: 1013-1025, 2009.
15. Levkau B, Hermann S, Theilmeier G, van der Giet M, Chun J, Schober O, Schäfers M. High-density lipoprotein stimulates myocardial perfusion in vivo. Circulation 110: 3355-3359, 2004.
16. Means C, Xiao C, Li Z, Zhang T, Omens J, Ishii I, Chun J, Brown J. Sphingosine 1-phosphate S1P2 and S1P3 receptor-mediated Akt activation protects against in vivo myocardial ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol 292: H2944-H2951, 2007.
17. Means CK, Brown JH. Sphingosine 1-phosphate receptor signalling in the heart. Cardiovasc Res 82: 193-200, 2009.
18. Nofer JR, van der Giet M, Tölle M, Wolinska I, von Wnuck Lipinski K, Baba HA, Tietge UJ, Gödecke A, Ishii I, Kleuser B, Schäfers M, Fobker M, Zidek W, Assmann G, Chun J, Levkau B. HDL induces NO-dependent vasorelaxation via the lysophospholipid receptor S1P3. J Clin Invest 113: 569-581, 2004.
19. Olsen J, Vermeulen M, Santamaria A, Kumar C, Miller M, Jensen L, Gnad F, Cox J, Jensen S, Nigg E, Bruna S, Mann M. Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis. Sci Signal 3: ra3, 2010.
20. Oskouian B, Sooriyakumaran P, Borowsky A, Crans A, DIllard-Telm L, Tam Y, Bandhuvula P, Saba J. Sphingosine-1-phosphate lyase potentiates apoptosis via p53- and p38-dependent pathways and is downregulated in colon cancer. Proc Natl Acad Sci USA 103: 17384-17389, 2006.
21. Sattler K, Levkau B. Sphingosine-1-phosphate as a mediator of highdensity lipoprotein effects in cardiovascular protection. Cardiovasc Res 82: 201-211, 2009.
22. Schmahl J, Raymond CS, Soriano P. PDGF signaling specificity is mediated through multiple immediate early genes. Nat Genet 39: 52-60, 2007.
23. Schwab S, Pereira J, Matloubian M, Xu Y, Huang Y, Cyster J. Lymphocyte sequestration through S1P lyase inhibition an disruption of S1P gradients. Science 309: 1735-1739, 2005.
24. Serra M, Saba JD. Sphingosine 1-phosphate lyase, a key regulator of sphingosine 1-phosphate signaling and function. Adv Enzyme Regul 50: 349-362, 2010.
25. Siow D, Anderson C, Berdyshev E, Skobeleva A, Pitson S, Wattenberg B. Intracellular localization of sphingosine kinase 1 alters access to substrate pools but does not affect the degradative fate of sphingosine-1- phosphate. J Lipid Res 51: 2546-2559, 2010.
26. Strub GM, Paillard M, Liang J, Gomez L, Allegood JC, Hait NC, Maceyka M, Price MM, Chen Q, Simpson DC, Kordula T, Milstien S, Lesnefsky EJ, Spiegel S. Sphingosine-1-phosphate produced by sphingosine kinase 2 in mitochondria interacts with prohibitin 2 to regulate complex IV assembly and respiration. FASEB J 25: 600-612, 2011.
27. Sullards MC, Merrill AHJ. Analysis of sphingosine-1-phosphate, ceramides, and other bioactive sphingolipids by high-performance liquid chromatography. Sci STKE 67: 1-11, 2001.
28. Takuwa Y, Okamoto Y, Yoshioka K, Takuwa N. Sphingosine-1- phosphate signaling and biological activities in the cardiovascular system. Biochim Biophys Acta 1781: 483-488, 2008.
29. Tao R, Hoover H, Honbo N, Kalinowski M, Alano C, Karliner J, Raffai R. High-density lipoprotein determines adult mouse cardiomyocyte fate after hypoxia/reoxygenation through lipoprotein-associated sphingosine-1-phosphate. Am J Physiol Heart Circ Physiol 298: H1022-H1028, 2010.
30. Tao R, Hoover H, Zhang J, Honbo N, Alano C, Karliner J. Cardiomyocyte S1P1 receptor-mediated ERK signaling and desensitization. J Cardiovasc Pharmacol 53: 486-494, 2009.
31. Tao R, Zhang J, Vessey D, Honbo N, Karliner J. A sphingosine kinase-1 mutation determines cell fate during hypoxia in adult mouse cardiomyocytes. Cardiovasc Res 74: 56-63, 2007.
32. Vessey D, Li L, Honbo N, Karliner J. Sphingosine 1-phosphate is an important endogenous cardioprotectant released by ischemic pre- and postconditioning. Am J Physiol Heart Circ Physiol 297: H1429-H1435, 2009.
33. Vessey DA, Kelley M, Li L, Huang Y, Zhou HZ, Zhu BQ, Karliner JS. Role of sphingosine kinase activity in protection of heart against ischemia reperfusion injury. Med Sci Monit 12: BR318-BR324, 2006.
34. Vogel P, Donoviel M, Read R, Hansen G, Hazlewood J, Anderson S, Sun W, Swaffield J, Oravecz T. Incomplete inhibition of sphingosine 1-phosphate lyase modulates immune system function yet prevents early lethality and non-lymphoid lesions. PLoS ONE 4: e4112, 2009.
35. Zhan X, Desiderio DM. Nitroproteins from a human pituitary adenoma tissue discovered with a nitrotyrosine affinity column and tandem mass spectrometry. Anal Biochem 354: 279-289, 2006.
36. Zhang J, Honbo N, Goetzl EJ, Chatterjee K, Karliner JS, Gray MO. Signals from type 1 sphingosine 1-phosphate receptors enhance adult mouse cardiac myocyte survival during hypoxia. Am J Physiol Heart Circ Physiol 293: H3150-H3158, 2007.
37. Zhou J, Saba J. Identification of the first mammalian sphingosine phosphate lyase gene and its functional expression in yeast. Biochem Biophys Res Commun 242: 502-507, 1998.